Body Weight Changes
Body Weight Changes
Explore linked clinical trials. Standard reference: MESH:M0002759475 results · Page 1 of 19
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Benefits of Nutritional Supplement in Cancer Care | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Not yet recruiting | Not applicable | 2026-10-09 | NCT07869290 | |
| Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Not yet recruiting | Phase 3 | 2026-10-09 | NCT07868939 | |
| Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Not yet recruiting | Phase 3 | 2026-10-09 | NCT07868835 | |
| Hospital-Based Prospective Cohort of Malnutrition Under 6-Month Study (HOSPIC-6-Study) | Body Weight, Body Weight Changes, Cachexia, Infant Malnutrition, Infant Nutrition Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, nutritional deficiency disease, nutritional disorder | Recruiting | Not stated | 2026-10-09 | NCT07831343 | |
| Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study | Body Weight, Body Weight Changes, Gestational Weight Gain, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Gain, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-10-09 | NCT06666257 | |
| Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Recruiting | Not applicable | 2026-10-08 | NCT07866183 | |
| Weight Loss Composition and Metabolic Adaptation During Hypocaloric Dieting | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not applicable | 2026-10-08 | NCT07627256 | |
| Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-10-08 | NCT07144800 | |
| Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 2 | 2026-10-08 | NCT00739362 | |
| Phentermine's Impact on Treatment in Teens | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 2 | 2026-10-07 | NCT07282340 | |
| Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2026-10-06 | NCT07560579 | |
| Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-10-06 | NCT06325722 | |
| Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Gain, morbid obesity, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-10-05 | NCT07859176 | |
| Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Gain, morbid obesity, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-10-05 | NCT07859163 | |
| Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE) | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Gain, morbid obesity, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-10-05 | NCT07859150 | |
| GLP-1s to Enhance Lasting Optimal Weight | Atrophy, Body Weight, Body Weight Changes, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 4 | 2026-10-02 | NCT06861439 | |
| Metabolism and Nutrition in MND | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, Weight Loss, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Not yet recruiting | Not stated | 2026-10-01 | NCT07851714 | |
| Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer | Body Weight, Body Weight Changes, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, Weight Loss, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, uterine disorder | Not yet recruiting | Phase 2 | 2026-10-01 | NCT07820358 | |
| A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Phase 3 | 2026-10-01 | NCT07775404 | |
| A Novel Intervention for Weight Loss in Young Adults | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Recruiting | Not applicable | 2026-10-01 | NCT06230744 | |
| DUTCH Weight Control in Atrial Fibrillation Study | Arrhythmias, Cardiac, Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, atrial fibrillation, cardiovascular disorder, heart disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 4 | 2026-10-01 | NCT06184633 | |
| Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported Communities | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, prediabetes syndrome | Not yet recruiting | Not applicable | 2026-09-30 | NCT07850531 | |
| GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer | Body Weight, Body Weight Changes, Nausea, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Skin and Connective Tissue Diseases, Vomiting, Weight Loss, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not applicable | 2026-09-30 | NCT07465172 | |
| Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial | Apnea, Body Weight, Body Weight Changes, Dyssomnias, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, Weight Loss, nervous system disorder, nutritional disorder, obesity disorder, obstructive sleep apnea syndrome, overnutrition, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-29 | NCT07846865 | |
| A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Recruiting | Phase 1 | 2026-09-29 | NCT07846033 |